# Abbott plans to close Alere acquisition on October 3

Abbott plans to close its acquisition of Alere on October 3, 2017, after receiving anti-trust approvals. The deal is valued at $5.3 billion, down from the initial $5.8 billion. Abbott will divest certain assets to Siemens and Quidel.

- Type: Acquisition
- Announced: 2017-09-29
- Where: United States
- Value: $5.30B
- Status: announced
- Products: point-of-care diagnostic tests, blood gas testing systems, heart function testing systems
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [Siemens](https://endata.com/companies/301.md) (partner)
- [Abbott](https://endata.com/companies/4479.md) (acquirer)
- [Alere](https://endata.com/companies/23753.md) (target)
- [Quidel](https://endata.com/companies/27253.md) (partner)

## Sources

- [massdevice.com](https://www.massdevice.com/abbott-plans-close-5b-alere-buyout-next-week/), 2017-09-29: "Creating the world’s leading point of care business will help Abbott meet the growing demand for fast, accurate and actionable information"

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.